2712529-19-4
Chemical Structure
HBV-IN-14
- CAS No.: 2712529-19-4
- Formula:C22H21ClN2O5
- Molecular Weight:428.87
IUPAC Name: (1s,3s)-3-(2-(4-(9-chloro-4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yl)phenoxy)ethoxy)-1-methylcyclobutane-1-carboxylic acid
InChIKey: PPNNMEWMZNATRX-MIRVZWSXSA-N
SMILES: O=C1C=C(C2=CC=C(C=C2)OCCO[C@H]3C[C@](C)(C3)C(O)=O)N=C4N1C=CC=C4Cl
Biological Activity: HBV-IN-14 is a potent inhibitor of covalently closed circular DNA (cccDNA). cccDNA serves as the template for viral RNA transcription and subsequent viral DNA generation. HBV-IN-14 is a pyridinopyrimidinones compound. HBV-IN-14 has the potential for the research of HBV infection (extracted from patent WO2021190502A1, compound 5)[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
HBV-IN-14 | HBV-IN-14 is a potent inhibitor of covalently closed circular DNA (cccDNA). cccDNA serves as the template for viral RNA transcription and subsequent viral DNA generation. HBV-IN-14 is a pyridinopyrimidinones compound. HBV-IN-14 has the potential for the research of HBV infection (extracted from patent WO2021190502A1, compound 5). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
